Status:
RECRUITING
Investigating Epilepsy: Screening and Evaluation
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Seizures
Epilepsy
Eligibility:
All Genders
8-110 years
Brief Summary
Background: Epilepsy affects about 1 percent of the U.S. population. Most people with epilepsy respond well to medicine, but some do not. Researchers want people who have diagnosed or suspected epile...
Detailed Description
Study Description:\<TAB\> This protocol is designed to serve as a screening protocol that provides standard evaluation and treatment for patients with epilepsy. Clinical data collected through this p...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age 8 years or older
- Known or suspected diagnosis of epilepsy
- Ability to give informed consent or have a legally authorized representative able to give consent (for adults without consent capacity) or parent/guardian able to provide informed consent (for a child)
- If unable to give informed consent, ability to give assent (for minors 8 and older)
- EXCLUSION CRITERIA:
- Patients with unstable medical conditions that, in the opinion of the investigators, makes participation unsafe, or who, in the opinion of the investigators may be unable to comply with the protocol
- Patients who are unable to travel to the NIH
Exclusion
Key Trial Info
Start Date :
March 28 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03478852
Start Date
March 28 2018
End Date
July 30 2027
Last Update
October 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892